Phase III/IV, Randomized, Fifty-Two-Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus.
Ellen GinzlerLuiz Sergio Guedes BarbosaDavid D'CruzRichard A FurieKathleen Maksimowicz-McKinnonJames OatesMittermayer Barreto SantiagoAmit SaxenaSaira Z SheikhDamon L BassSusan W BurrissJennifer A GilbrideJames G GroarkMichelle MillerAmy PierceDavid A RothBeulah JiPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2021)
The primary end point of this study was not achieved, but improvement with belimumab versus placebo was observed, suggesting that belimumab remains a suitable treatment option for SLE management in patients of Black African ancestry.